Wednesday, November, 20, 2019 08:08:40

Category: Health

Medlab, Chronic Pain Australia to promote info on medicinal cannabis

Medlab Clinical currently has two cannabis-based drugs, namely NanaBidial™ and NanaBis™ that contain formulations of cannabidiol (CBD) and tetrahydrocannabinol (THC). Australia’s scientific research company, Medlab Clinical Ltd. has recently entered into a collaborative agreement with Chronic Pain Australia to promote the knowledge of medicinal cannabis …

ImmunoPrecise & TetraGenetics extend antibody discovery agreement

Immunoprecise Antibodies Ltd. has recently declared the extension of its association with TetraGenetics, a biopharma firm developing new therapeutics for autoimmune illnesses. Sources close to the development claim that the alliance is aimed at the discovery of new human monoclonal antibodies against three unrevealed therapeutically-relevant …

MediciNova announces outcomes of the SPRINT-MS Phase 2b Trial

This analysis was aimed to understand the types of progressive MS subjects that responds best to MN-166 (ibudilast) treatment MediciNova, Inc., the biopharmaceutical firm listed on the Tokyo Stock Exchange’s JASDAQ Market and NASDAQ Global Market, has reportedly announced outcomes of the SPRINT-MS Phase 2b …